Extended Data Fig. 8: Overall Survival by Prior Midostaurin in the AdvSM Safety Population.
From: Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
AdvSM, advanced systemic mastocytosis.
Extended Data Fig. 8: Overall Survival by Prior Midostaurin in the AdvSM Safety Population. | Nature Medicine
